Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis
Advanced Science · 2025
DOI: 10.1002/advs.202411368 ↗At a glance
Journal article in Advanced Science, 2025. Written by Qinglin Zhang and 4 co-authors. Institution: School of Biological Sciences, The University of Hong Kong, Hong Kong, SAR, 999077, China. Major MEDLINE topics: Liver Neoplasms, Carcinoma, Hepatocellular, Mechanistic Target of Rapamycin Complex 1, Lipogenesis. Cited 3 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Research Grants Council of Hong Kong China, National Natural Science Foundation of China.
Abstract (original language)
Hepatocellular carcinoma (HCC) is the predominant form of primary liver cancer and a major contributor to cancer‐related mortality globally. Central to its pathogenesis is the dysregulation of lipid metabolism in hepatocytes, leading to abnormal lipid accumulation. Our bioinformatics analysis has identified the histone acetyltransferase complex subunit VPS72 as being associated with HCC, yet the precise molecular mechanisms through which VPS72 contributes to hepatocarcinogenesis remain poorly understood. Our analysis of extensive HCC patient cohorts identifies a significant proportion with VPS72 copy number gains, which are strongly linked to adverse prognostic outcomes. By integrating RNA‐Seq, ChIP‐Seq, ATAC‐seq, and experimental validation, we show that VPS72 overexpression activates mTORC1 signaling, subsequently promoting lipid synthesis and driving HCC progression. We further uncover that VPS72 modulates the epigenetic landscape by enhancing DNA methylation at the ATF3 promoter, resulting in ATF3 repression and subsequent activation of mTORC1. This study elucidates a novel regulatory axis that links dysregulated lipid metabolism with HCC progression, highlighting potential epigenetic and metabolic targets for therapeutic intervention.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Biological Sciences, The University of Hong Kong, Hong Kong, SAR, 999077, China.
- Department of Pathology, School of Clinical Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong, SAR, 999077, China.
- Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong, SAR, 999077, China.
ORCID profiles: Qinglin Zhang, Jiangwen Zhang
Funding
- Research Grants Council of Hong Kong China
- National Natural Science Foundation of China
Cite
APA
Zhang, Q., Huang, Y., Tong, Y., Ng, K. T. C., & Zhang, J. (2025). Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis. Advanced Science. https://doi.org/10.1002/advs.202411368
Vancouver
Zhang Q, Huang Y, Tong Y, Ng KTC, Zhang J. Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis. Advanced Science. 2025. doi:10.1002/advs.202411368
BibTeX
@article{Zhang2025,
author = {Zhang, Qinglin and Huang, Yunxing and Tong, Yin and Ng, Kenneth Tsz Chun and Zhang, Jiangwen},
title = {Copy Number Gains of VPS72 Drive De Novo Lipogenesis and Hepatocarcinogenesis via ATF3/mTORC1/SREBP1 Axis},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202411368}
}
EUVIMED